NDC11 63323061403
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63323-0614-03 | 63323-0614 |
| 63323-0614-3 | 63323-0614 |
| 63323-614-03 | 63323-614 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | bf1b7c2f-535c-45bb-928a-65606d87685e | 2025-12-16 | Warnings, Adverse reactions | 63323-614-03 63323-614 63323061403 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | f34904dc-c945-4de4-8594-34e4f4ac1983 | 2025-11-28 | Warnings, Adverse reactions | 63323-614 |
| hydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | c3797028-c625-4f70-ae69-8a5f6f23f1b8 | 2022-08-09 | Warnings, Adverse reactions | 63323-614 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 8223c44a-73a9-4da5-a468-d1d8bdb0bbd6 | 2022-05-18 | Warnings, Adverse reactions | 63323-614 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.